Search

Your search keyword '"Moisés Diago"' showing total 4 results
Start Over Author "Moisés Diago" Journal digestive and liver disease
4 results on '"Moisés Diago"'

1. T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study

Author

E.J. Lawitz, Ralph DeMasi, Andrzej Horban, Graham R. Foster, I. Lonjon-Domanec, G. Picchio, Steven Roberts, Z.M. Younossi, James Witek, R. van Heeswijk, Stanislas Pol, S. Zeuzem, P. Andreone, Moisés Diago, and R. Focaccia

Subjects
medicine.medical_specialty, Hepatology, Anemia, business.industry, Ribavirin, Gastroenterology, medicine.disease, Treatment failure, Telaprevir, Regimen, chemistry.chemical_compound, chemistry, Hcv genotype 1, Internal medicine, medicine, Dose reduction, In patient, business, medicine.drug
Published
2012

2. T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study

Author

S. Zeuzem, G. Picchio, B. Coate, Z.M. Younossi, Stanislas Pol, Moisés Diago, Ralph DeMasi, I. Lonjon-Domanec, R. Focaccia, Lawrence Serfaty, Graham R. Foster, E.J. Lawitz, Steven Roberts, P. Andreone, Andrzej Horban, Francesco Negro, and James Witek

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Treatment failure, Telaprevir, Regimen, Insulin resistance, Hcv genotype 1, Virologic response, Internal medicine, Post-hoc analysis, medicine, In patient, business, medicine.drug
Published
2012

3. T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study

Author

Andrzej Horban, Graham R. Foster, I. Lonjon-Domanec, G. Picchio, E.J. Lawitz, R. van Heeswijk, P. Andreone, S. Zeuzem, Stanislas Pol, Z.M. Younossi, Steven Roberts, Moisés Diago, Ralph DeMasi, R. Focaccia, James Witek, and S. DeMeyer

Subjects
medicine.medical_specialty, Hepatology, Hcv genotype 1, business.industry, Internal medicine, Gastroenterology, Medicine, PEGINTERFERON/RIBAVIRIN, business, Treatment failure, Telaprevir, medicine.drug
Published
2012

4. T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study

Author

I. Lonjon-Domanec, Steven Roberts, Stanislas Pol, Andrzej Horban, Thomas Berg, James Witek, S. Zeuzem, G. Picchio, R. Focaccia, P. Andreone, Ralph DeMasi, E.J. Lawitz, Z.M. Younossi, Graham R. Foster, and Moisés Diago

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, PEGINTERFERON/RIBAVIRIN, Treatment failure, Telaprevir, Combined treatment, Hcv genotype 1, Internal medicine, Virologic response, Post-hoc analysis, medicine, business, medicine.drug
Published
2012

Catalog

Books, media, physical & digital resources
See catalog results